immatics biotechnologies GmbH
Patents, Design & Utilities

Last updated:

List of all immatics biotechnologies GmbH patents 820 in total

Status Patent
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS External link
Filling date: 7 Sep 2025 Issue date: 8 Sep 2022
Application
Utility: METHOD FOR THE ABSOLUTE QUANTIFICATION OF MHC MOLECULES External link
Filling date: 7 Sep 2025 Issue date: 8 Sep 2022
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against various tumors External link
Filling date: 7 Sep 2025 Issue date: 6 Sep 2022
Grant
Utility: Immunotherapy with B*08 restricted peptides and combination of peptides against cancers and related methods External link
Filling date: 7 Sep 2025 Issue date: 6 Sep 2022
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against various tumors External link
Filling date: 7 Sep 2025 Issue date: 6 Sep 2022
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against various cancers External link
Filling date: 7 Sep 2025 Issue date: 6 Sep 2022
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS External link
Filling date: 7 Sep 2025 Issue date: 1 Sep 2022
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers External link
Filling date: 7 Sep 2025 Issue date: 30 Aug 2022
Grant
Utility: Peptides and combination thereof for use in the immunotherapy against cancers External link
Filling date: 7 Sep 2025 Issue date: 30 Aug 2022
Application
Utility: IMMUNOTHERAPY WITH B*07 RESTRICTED PEPTIDES AND COMBINATION OF PEPTIDES AGAINST CANCERS AND RELATED METHODS External link
Filling date: 7 Sep 2025 Issue date: 25 Aug 2022
Application
Utility: NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING GASTROINTESTINAL AND GASTRIC CANCER External link
Filling date: 7 Sep 2025 Issue date: 25 Aug 2022
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS External link
Filling date: 7 Sep 2025 Issue date: 25 Aug 2022
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS External link
Filling date: 7 Sep 2025 Issue date: 18 Aug 2022
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS External link
Filling date: 7 Sep 2025 Issue date: 18 Aug 2022
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS External link
Filling date: 7 Sep 2025 Issue date: 18 Aug 2022
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers External link
Filling date: 7 Sep 2025 Issue date: 16 Aug 2022
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers External link
Filling date: 7 Sep 2025 Issue date: 16 Aug 2022
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers External link
Filling date: 7 Sep 2025 Issue date: 16 Aug 2022
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers External link
Filling date: 7 Sep 2025 Issue date: 16 Aug 2022
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS External link
Filling date: 7 Sep 2025 Issue date: 11 Aug 2022
Application
Utility: PEPTIDES AND T CELLS FOR USE IN IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS CANCERS External link
Filling date: 7 Sep 2025 Issue date: 11 Aug 2022
Application
Utility: PEPTIDES AND T CELLS FOR USE IN IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS CANCERS External link
Filling date: 7 Sep 2025 Issue date: 11 Aug 2022
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers External link
Filling date: 7 Sep 2025 Issue date: 9 Aug 2022
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against various tumors External link
Filling date: 7 Sep 2025 Issue date: 9 Aug 2022
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against various tumors External link
Filling date: 7 Sep 2025 Issue date: 9 Aug 2022
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against various tumors External link
Filling date: 7 Sep 2025 Issue date: 9 Aug 2022
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against various tumors External link
Filling date: 7 Sep 2025 Issue date: 9 Aug 2022
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers External link
Filling date: 7 Sep 2025 Issue date: 9 Aug 2022
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST SMALL CELL LUNG CANCER AND OTHER CANCERS External link
Filling date: 7 Sep 2025 Issue date: 4 Aug 2022
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers External link
Filling date: 7 Sep 2025 Issue date: 2 Aug 2022
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers External link
Filling date: 7 Sep 2025 Issue date: 2 Aug 2022
Application
Utility: PEPTIDES AND T CELLS FOR USE IN IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS CANCERS External link
Filling date: 7 Sep 2025 Issue date: 28 Jul 2022
Application
Utility: PEPTIDES AND T CELLS FOR USE IN IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS CANCERS External link
Filling date: 7 Sep 2025 Issue date: 28 Jul 2022
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS External link
Filling date: 7 Sep 2025 Issue date: 28 Jul 2022
Application
Utility: PEPTIDES AND T CELLS FOR USE IN IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS CANCERS External link
Filling date: 7 Sep 2025 Issue date: 21 Jul 2022
Application
Utility: PEPTIDES DISPLAYED BY HLA FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS External link
Filling date: 7 Sep 2025 Issue date: 21 Jul 2022
Grant
Utility: Uterine cancer treatments External link
Filling date: 7 Sep 2025 Issue date: 19 Jul 2022
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers External link
Filling date: 7 Sep 2025 Issue date: 12 Jul 2022
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers External link
Filling date: 7 Sep 2025 Issue date: 12 Jul 2022
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers External link
Filling date: 7 Sep 2025 Issue date: 12 Jul 2022
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS External link
Filling date: 7 Sep 2025 Issue date: 7 Jul 2022
Grant
Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers External link
Filling date: 7 Sep 2025 Issue date: 5 Jul 2022
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers External link
Filling date: 7 Sep 2025 Issue date: 28 Jun 2022
Grant
Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers External link
Filling date: 7 Sep 2025 Issue date: 28 Jun 2022
Application
Utility: DUAL SPECIFICITY POLYPEPTIDE MOLECULE External link
Filling date: 7 Sep 2025 Issue date: 23 Jun 2022
Application
Utility: IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING LUNG CANCER External link
Filling date: 7 Sep 2025 Issue date: 23 Jun 2022
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against various tumors External link
Filling date: 7 Sep 2025 Issue date: 21 Jun 2022
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against various tumors External link
Filling date: 7 Sep 2025 Issue date: 21 Jun 2022
Application
Utility: DUAL SPECIFICITY POLYPEPTIDE MOLECULE External link
Filling date: 7 Sep 2025 Issue date: 16 Jun 2022
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC AND OTHER CANCERS External link
Filling date: 7 Sep 2025 Issue date: 16 Jun 2022

Showing 1 to 50 of 820 patents.